US2010279949A1PendingUtilityA1

Process for preparing recombinant heterocarpine

Assignee: FERRANDIS ERICPriority: Dec 10, 2002Filed: Dec 4, 2008Published: Nov 4, 2010
Est. expiryDec 10, 2022(expired)· nominal 20-yr term from priority
Inventors:Eric Ferrandis
A61P 35/00C07K 14/415A61K 38/00
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A process for preparing recombinant heterocarpine with the complete sequence of heterocarpine (SEQ. ID. NO. 10), expression vectors comprising a polynucleotide encoding for heterocarpine, host cells transformed or transfected by said expression vectors as well as a process for obtaining heterocarpine by means of said transformed or transfected host cells are described wherein the recombinant heterocarpine obtained is used to treat cancer.

Claims

exact text as granted — not AI-modified
1 - 5 . (canceled) 
     
     
         6 . An isolated polypeptide comprising the sequence SEQ.ID.NO.14. 
     
     
         7 . An isolated polypeptide according to  claim 6 , wherein it is a polypeptide of sequence SEQ.ID.NO.14. 
     
     
         8 - 14 . (canceled) 
     
     
         15 . A pharmaceutical composition comprising, as active ingredient, a polypeptide according to  claim 6  and an inert carrier. 
     
     
         16 - 18 . (canceled) 
     
     
         19 . A method of treating a proliferative disease in a warm-blooded animal comprising administrating to a warm-blooded animal in need thereof, an amount of polypeptide of  claim 6  sufficient to treat said disease. 
     
     
         20 . A pharmaceutical composition comprising a polypeptide of  claim 7  and an inert carrier. 
     
     
         21 . A method of treating a proliferative disease in a warm-blooded animal comprising administrating to a warm-blooded animal in need thereof, an amount of polypeptide of  claim 7  sufficient to treat said disease.

Join the waitlist — get patent alerts

Track US2010279949A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.